MedPath

Assessment of the effect of lidocaine on seizure duration and hemodynamic changes in electroconvulsive therapy

Not Applicable
Conditions
ECT.
Depressive episode
Registration Number
IRCT201105103912N2
Lead Sponsor
Shahrekord University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
72
Inclusion Criteria

age between 20-40 years, psychiatric disorders with ASAI-II, candidate for ECT
Exclusion criteria: heart failure, cardiac arrhythmia, drug hypersensitivity, drug abuse

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of seizure. Timepoint: after intervention. Method of measurement: clinical observation.;Blood Pressure. Timepoint: Before and immediately 3 and 5 minutes after ECT. Method of measurement: Pulse Oximetry.;Pulse Rate. Timepoint: Before and immediately and 3 and 5 minutes after ECT. Method of measurement: Pulse Oximetry.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath